Michael Scherlag

Title: Michael Scherlag: Innovator in Cardiac Treatment

Introduction

Michael Scherlag is a notable inventor based in Oklahoma City, OK (US). He has made significant contributions to the field of cardiac treatment through his innovative patent. His work focuses on methods to control cardiac arrhythmias, which can have life-saving implications for patients.

Latest Patents

Michael Scherlag holds a patent for a "Method and apparatus for transvascular treatment of tachycardia and fibrillation." This invention provides a method of controlling cardiac fibrillation, tachycardia, or cardiac arrhythmia by utilizing an electrophysiology catheter. The catheter features a tip section that contains at least one stimulating electrode, which is stably placed at a selected intravascular location. The electrode is connected to a stimulating means, allowing stimulation to be applied across the wall of the vessel, transvascularly, to a sympathetic or parasympathetic nerve that innervates the heart. This stimulation is applied at a strength sufficient to depolarize the nerve and effectively control the heart.

Career Highlights

Throughout his career, Michael Scherlag has demonstrated a commitment to advancing medical technology. His innovative approach to cardiac treatment has the potential to improve patient outcomes significantly. With 1 patent to his name, he continues to be a valuable contributor to the medical field.

Collaborations

Michael has worked alongside notable colleagues, including Wilton W Webster, Jr. and Benjamin J Scherlag. Their collaborative efforts have furthered research and development in cardiac treatment technologies.

Conclusion

Michael Scherlag's contributions to cardiac treatment through his innovative patent highlight the importance of advancements in medical technology. His work not only showcases his expertise but also emphasizes the potential for improving patient care in the field of cardiology.